Roger C. Denton, Founding Partner of Schlichter, Bogard & Denton, LLP, Selected as a 2013 Super Lawyer®
Schlichter, Bogard & Denton, LLP is proud to announce that Roger C. Denton has been selected as a 2013 Super Lawyer®, which is a distinction given to attorneys who have attained a high-degree of peer recognition and professional achievement. The selection process involves independent research by Thomson Reuters, along with consideration of peer nominations and evaluations.
Roger C. Denton is a founding partner and the chair of the Pharmaceutical Litigation Department at Schlichter, Bogard & Denton, LLP. Mr. Denton has devoted his legal career to representing individuals who have been seriously injured. Mr. Denton has extensive experience litigating pharmaceutical products liability cases involving defective drugs and devices, representing thousands of clients. Mr. Denton has obtained numerous multi-million dollar verdicts and settlements against Fortune 500 companies and other corporations, building his reputation as an aggressive litigator and trial attorney.
Mr. Denton graduated in 1978, cum laude, with a Bachelor of Arts Degree from Culver-Stockton College in Missouri. He attended law school at St. Louis University School of Law, where he was a member of the Law Journal, and obtained his Juris Doctor in 1982, graduating summa cum laude. He was admitted to practice law in 1982 in Illinois, in 1983 in Missouri, and in 1998 in Wisconsin. He is also admitted to practice before the United Supreme Court, the United States Courts of Appeals for the Seventh and Eighth Circuits, and the United States District Courts in Illinois, Indiana, Missouri, and Wisconsin. Mr. Denton’s “AV” rating in Martindale-Hubbell is the highest level available and represents the judgment of his peers about his professionalism, quality and expertise in legal work, and ethics. Mr. Denton is an Executive Board Member of the Mass Tort Trial Lawyer Association, a member of the American Association for Justice, a member of the Illinois Trial Lawyers Association and a member of Missouri Association of Trial Attorneys. He is also a frequent speaker at national and local seminars and conferences involving mass torts and pharmaceutical litigation.
Mr. Denton has a national reputation as a leader in pharmaceutical litigation. He is acting as MDL Liaison Counsel in the Multidistrict Litigation In re Yasmin® and Yaz® (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100), having been appointed by Chief Judge David Herndon of the Southern District of Illinois. Mr. Denton is Co-Lead Counsel in the Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL 1964), having been appointed by Judge Rodney Sippel of the Eastern District of Missouri; the Multidistrict Litigation In Re: E.I. Du Pont De Nemours and Company C-8 Personal Injury Litigation (MDL 2433), having been appointed by Judge Edmund Sargus of the Southern District of Ohio; and the Multidistrict Litigation In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation (MDL 2385), having been appointed by Chief Judge Herndon of the Southern District of Illinois. Mr. Denton has also served on the National Plaintiffs’ Steering Committees in the Multidistrict Litigation In re Ortho Evra® Products Liability Litigation (MDL 1742), appointed by Judge David A. Katz of the Northern District of Ohio, as well as the Multidistrict Litigation In re Gadolinium-Based Contrast Agents Product Liability Litigation (MDL 1909), appointed by Judge Dan A. Polster of the Northern District of Ohio. Mr. Denton is also active in the HRT Litigation pending in the City of St. Louis, Missouri Circuit Court, where he is representing women throughout the country who have breast cancer caused by hormone replacement drugs.
As a founding partner of Schlichter, Bogard & Denton, LLP, Mr. Denton represents clients throughout the United States. Schlichter, Bogard & Denton, LLP has a national reputation for being a leader in complex litigation matters, including dangerous pharmaceutical and unsafe medical device cases. Our highest priority at Schlichter, Bogard & Denton, LLP is our commitment to practicing law to the highest standard of excellence in every phase of the trial process.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.